Weiling Cao

499 total citations
20 papers, 338 citations indexed

About

Weiling Cao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiling Cao has authored 20 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiling Cao's work include RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Diabetes Treatment and Management (3 papers). Weiling Cao is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Diabetes Treatment and Management (3 papers). Weiling Cao collaborates with scholars based in China, Hong Kong and France. Weiling Cao's co-authors include Jing Ma, Haizhu Kuang, Mingyue Pan, Henggang Wang, Yue Shi, Chuanchuan Zhang, Peng Zhang, Xiaojing Ji, Zhenguang Wang and Yuting Cui and has published in prestigious journals such as Advanced Materials, Chemical Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Weiling Cao

19 papers receiving 334 citations

Peers

Weiling Cao

PRM

Zizhen Zhao China

Zhuo Yang China

Dongun Lee South Korea

Hussein Riyadh Abdul Kareem Al‐Hetty Iraq

Shiu-Huey Chou Taiwan

Jingsi Jiang China

Metin Çetįn Türkiye

Xinyi Peng China

Tiantian Liang China

Zizhen Zhao China

Weiling Cao

239 ×1.8

149 ×1.4

96 ×1.5

51 ×1.1

29 ×0.7

PRM

Citations per year, relative to Weiling Cao Weiling Cao (= 1×) peers Zizhen Zhao

Countries citing papers authored by Weiling Cao

Since Specialization

Citations

This map shows the geographic impact of Weiling Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling Cao more than expected).

Fields of papers citing papers by Weiling Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiling Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling Cao. The network helps show where Weiling Cao may publish in the future.

Co-authorship network of co-authors of Weiling Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Weiling Cao. A scholar is included among the top collaborators of Weiling Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiling Cao. Weiling Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Jing, et al.. (2025). Design of a quinoxalinone-based AIE probe for the detection of ROS in in vitro and in vivo sepsis models. Biomaterials Science. 13(12). 3298–3306. 2 indexed citations

Pan, Mingyue, et al.. (2025). mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review. International Journal of Biological Macromolecules. 309(Pt 4). 143134–143134. 1 indexed citations

Xie, Yuanyun, et al.. (2025). Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified Analysis. ClinicoEconomics and Outcomes Research. Volume 17. 771–787. 1 indexed citations

Xie, Yuanyun, et al.. (2025). Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss in Patients with Obesity or Overweight: A Systematic Review. Diabetes Metabolic Syndrome and Obesity. Volume 18. 2837–2849. 1 indexed citations

Yang, Shuping, et al.. (2024). Repurposing of Antidiarrheal Loperamide for Treating Melanoma byInducing Cell Apoptosis and Cell Metastasis Suppression In vitro andIn vivo. Current Cancer Drug Targets. 24(10). 1015–1030.

Li, Mengting, et al.. (2024). Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials. Metabolism. 161. 156038–156038. 16 indexed citations

Zhang, Peng, et al.. (2024). Effectiveness of metagenomic next-generation sequencing in the diagnosis of infectious diseases: A systematic review and meta-analysis. International Journal of Infectious Diseases. 142. 106996–106996. 10 indexed citations

Yang, Shuping, Zhi Li, Mingyue Pan, et al.. (2024). Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma. Anti-Cancer Drugs. 35(6). 512–524. 3 indexed citations

Li, Zhi, et al.. (2023). A PD‐L1 Antibody‐Conjugated PAMAM Dendrimer Nanosystem for Simultaneously Inhibiting Glycolysis and Promoting Immune Response in Fighting Breast Cancer. Advanced Materials. 35(41). e2305215–e2305215. 24 indexed citations

10.

Li, Zhi, et al.. (2023). A PD‐L1 Antibody‐Conjugated PAMAM Dendrimer Nanosystem for Simultaneously Inhibiting Glycolysis and Promoting Immune Response in Fighting Breast Cancer (Adv. Mater. 41/2023). Advanced Materials. 35(41). 4 indexed citations

11.

Kuang, Haizhu, et al.. (2023). Integrated Osteoinductive Factors─Exosome@MicroRNA-26a Hydrogel Enhances Bone Regeneration. ACS Applied Materials & Interfaces. 15(19). 22805–22816. 36 indexed citations

12.

Cui, Yuting, et al.. (2022). Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy. Frontiers in Pharmacology. 13. 1035882–1035882. 14 indexed citations

13.

Xu, Wanfeng, Yun Wang, Hai Huang, et al.. (2022). Octreotide-based therapies effectively protect mice from acute and chronic gastritis. European Journal of Pharmacology. 928. 174976–174976. 9 indexed citations

14.

Zhang, Zhi‐Qiang, et al.. (2022). Efficacy of anti‐fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta‐analysis. Mycoses. 65(10). 906–917. 5 indexed citations

15.

Chen, Haifei, et al.. (2021). miR‐218 contributes to drug resistance in multiple myeloma via targeting LRRC28. Journal of Cellular Biochemistry. 122(3-4). 305–314. 11 indexed citations

16.

Xu, Yingying, et al.. (2020). Recent progress in nanotechnology based ferroptotic therapies for clinical applications. European Journal of Pharmacology. 880. 173198–173198. 23 indexed citations

17.

Cui, Yuting, et al.. (2020). Recent progress in the use of mitochondrial membrane permeability transition pore in mitochondrial dysfunction-related disease therapies. Molecular and Cellular Biochemistry. 476(1). 493–506. 39 indexed citations

18.

Cui, Yuting, et al.. (2020). Traditional Chinese medicine classic herbal formula Qingjin Huatan decoction for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. European Journal of Integrative Medicine. 40. 101253–101253. 1 indexed citations

19.

Kuang, Haizhu, Yingying Xu, Leilei Shi, et al.. (2020). Rational Design of a High-Performance Quinoxalinone-Based AIE Photosensitizer for Image-Guided Photodynamic Therapy. ACS Applied Materials & Interfaces. 12(38). 42551–42557. 38 indexed citations

20.

Zhang, Chuanchuan, Peng Zhang, Xiaojing Ji, et al.. (2019). Ultrasonication-promoted synthesis of luminescent sulfur nano-dots for cellular imaging applications. Chemical Communications. 55(86). 13004–13007. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact